CDER Recruitment Wins Begin Outnumbering Losses
Executive Summary
US FDA's drug center has been hiring more employees than it has lost over the last few months and hopes the Office of New Drugs reorganization will help retention.
You may also be interested in...
New CDER Lab Will Help Push Advanced Manufacturing Adoption
US FDA plans to open a manufacturing research lab near its White Oak headquarters in 2021 to facilitate evaluation of novel manufacturing technology.
US FDA's Biosimilars Chief Leah Christl Plans Departure
A departure date has yet to be determined for the associate director of therapeutic biologics, who helped negotiate and implement the biosimilar user fee program.
As US FDA Shutdown Continues, What Will Be The Cost Of Not Spending?
Bolus of applications could be filed once government reopens, but employee morale and recruitment efforts could suffer drop-off.